EMA Authorised: Lynkuet (elinzanetant) — Bayer AG

View source ↗

Summary

The European Medicines Agency authorised Lynkuet (elinzanetant) from Bayer AG for menopausal symptoms including hot flashes and indications related to menopause…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Menopause

Drugs mentioned

• LYNKUET (elinzanetant)

Snippet

Status: Authorised. Therapeutic area: Hot Flashes;Menopause;Breast Neoplasms. MAH: Bayer AG. Decision date: 17/11/2025